| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-07 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-06 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-05 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |